Characterization of cisplatin resistance phenotype in A2780 and A2780cp cells. by Hadi Alizadeh (20854757)

Subjects:

Viability and drug resistance of A2780 cells following AGPAT3 overexpression. by Hadi Alizadeh (20854757)

Subjects:

Presenting the original images of Western blotting analysis. by Hadi Alizadeh (20854757)

Subjects:

Analysis of MD simulations for the SP domain of native PC and its mutant structures (L305R, W342C, G403R, V420E, and W444C) over 200 ns simulations. by Mahvash Farajzadeh-Dehkordi (17468232)

DAF-16/FOXO is Required for Locomotory Healthspan and Lifespan Benefits of Genetic Glycolysis Disruption. by Brian Onken (86790)

“…<i>daf-16</i> mutants are documented to have lowered locomotory ability vs. WT later in life [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008982#pgen.1008982.ref091" target="_blank">91</a>, <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008982#pgen.1008982.ref092" target="_blank">92</a>]; we note that, although comparison of scores across experiments is not possible due to variation in baseline values, the swimming rate of <i>daf-16(mgDf50)</i> control animals was slightly lower than WT controls on the same day of life (in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008982#pgen.1008982.g001" target="_blank">Fig 1C</a>; mean of 46.17 head thrashes/30 sec. for <i>daf-16</i> vs. 52.17 head thrashes/30 sec. for WT on day 10). …”

Transcriptomes of NS1-S1 and NS1^mTAD2-S1 cell lines treated with or without Dox. by Peng Xu (17962)

Mice with a decrease in α7 expression show no behavioral preference to a conditioned odor. by Jennifer L. Hellier (326477)

Effect of different doses (mg/Kg) of the defatted extract (DE) of the leaves of <i>S. malaccense</i> and <i>S. samarangense</i> on serum ALT and AST levels. Data represented as mea... by Fatma A. Moharram (9276104)

Duration-dependent effect of 50°C heat shock on the mRNA and protein levels in the stable transformants. by Nobuko Sumiya (648113)

Beta-catenin signaling is decreased in intermediate progenitor cells. by Christopher A. Mutch (243132)

“…<p>(<b>A</b>) Cortex from E14.5 Axin2-d2EGFP transgenic mice stained for GFP (green), Tbr2 (red), and DNA (blue). …”

Corticosterone treatment decreases MMP-2 promoter activity. by Eric A. Shikatani (131260)

Decreasing pixel differences caused by worm movement correspond to decreasing locomotive health. by Areta Jushaj (8525655)

Transient neonatal olfactory deprivation causes a persistent decrease in the addition of CR+ PGCs. A by Yasuko Kato (122938)

“…. & reopening group was used as a control (control). The number of PGCs was quantified at P61. …”

Decreased nephrin expression. by Sandra Müller-Krebs (485766)

Genes with decreased expression in TGFβ-induced EMT. by Kevin A. Maupin (190060)

Substance P decreases PRL immunoreactivity in human epidermis. by Ewan A. Langan (405804)

“…<p>Epidermal PRL IR (black arrows) was examined in full-thickness human skin organ culture. (A) PRL IR in the control group was significantly greater than that in (B) Substance P treated skin. …”

Inactivation of one allele of FT5. by Sophia Bigot (16469992)

The effect of α-MSH treatment on the permeability of cytokine treated Caco-2 monolayers. by Judit Váradi (507449)

Effect of RYGB on distribution of GLP-2 positive cells. by Ananyaa Sridhar (13844261)

Effect of RYGB on distribution of PYY positive cells. by Ananyaa Sridhar (13844261)